Skip to content
PeptideSport
Signos logo

Provider review

Signos review

By Derek Olsson ·

GLP-1 care with sensors for periodic glucose checks

Signos+ advertises medication, app support and Stelo sensors from $199/month. Its two-sensor 12-week or four-sensor 24-week allowance does not cover continuous wear for the whole plan, and stopping renewal leaves the current term's payments due.

Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

On this page

The verdict

Signos+ combines clinician-guided GLP-1 treatment with glucose feedback, nutrition support and an app. It advertises compounded semaglutide and tirzepatide, with your prescription determined by an independent clinician. The main tradeoffs are the term commitment and limited sensor supply: confirm the complete medication quote and budget for extra sensors if you want uninterrupted monitoring.

Signos isn't on any of our comparisons yet. The providers we compare in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see how semaglutide works for what the treatment does and does not do.

Alternatives to Signos

Other providers we work with. Compare prices before you sign up anywhere.

Who it is for, and who it is not

A good fit if

  • You want periodic glucose feedback alongside prescribed GLP-1 care and nutrition support.
  • You are comfortable with a 12- or 24-week plan and its remaining-payment obligations.
  • You want an app for medication logging, wellness check-ins and habit tracking.

Look elsewhere if

  • You need continuous sensor coverage throughout the entire subscription at the starting price.
  • You want unused time prorated after canceling the current term.
  • You need a confirmed drug, dose, dispensing pharmacy and total charge before enrollment.

What it actually costs

What they advertise

Signos+ starts at $199/month for eligible members, with a three- or six-month treatment plan; the selected medication and full term charge need confirmation.

What you actually pay, month to month

Advertised from $199/month for Signos+. This is a starting offer, not a confirmed dose-specific prescription, full-term invoice or renewal quote.

The commitment trap

Canceling auto-renewal takes effect after the current subscription term; remaining payments continue. Early termination may carry a fee, with no prorated refund of unused time.

Money you will meet later

  • The product guide lists additional sensors at $99 per two-pack. CGM-only plans and their sensor allowances are separate from Signos+.
  • A clinician may require updated labs; the patient lab panel and payer are not confirmed.
  • Confirm the exact early-termination fee, next renewal amount and any extra medication or administration costs before agreeing to the plan.

Prices come from Signos's own website and can change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.

What is included

Compare the total cost, including fees and any minimum commitment. Here is what Signos bundles in, and what it does not.

Clinician consult

Independent clinician evaluation included

OpenLoop Health and other independent networks assess treatment eligibility; a prescription is not guaranteed.

Bloodwork / labs

Required labs may cost extra

Updated testing can depend on clinical history; no universally funded patient panel or allowance was established.

Follow-ups and dose changes

Monthly wellness check-ins described

Complete required clinician check-ins to avoid refill delays; missed-refill refunds are excluded when check-ins are incomplete.

Human support

Nutrition and app support included

The product guide describes one-to-one nutrition support; confirm the clinical team's contact channel and availability for treatment questions.

Injection supplies

Periodic sensors included

two for the 12-week plan and four for the 24-week plan, each intended for up to 15 days of wear, plus six overpatches. Confirm injection-supply quantities separately.

Shipping

Free shipping advertised

Medication is described as shipping monthly after clinical approval and any required check-in; no individual dispatch or arrival date is confirmed.

Pharmacy, labs and oversight

The pharmacy

Dispensing pharmacy not identified. Signos Inc. provides the platform; OpenLoop Health and independent clinicians provide medical services. Public disclosures describe U.S. pharmacy partners without identifying your assigned dispenser or facility category.

Oversight

Monthly wellness check-ins described. Complete required clinician check-ins to avoid refill delays; missed-refill refunds are excluded when check-ins are incomplete.

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.

Where you can get it

Louisiana excluded from Signos+. The GLP-1 page advertises 49 states plus DC, with location-specific video requirements and clinical eligibility. General CGM shipping coverage does not establish GLP-1 treatment access.

The honest cons

The part they would rather you skipped

The supplied sensors are for targeted use, so the medication-and-CGM bundle does not buy uninterrupted monitoring throughout the term. You also remain responsible for current-term payments after stopping renewal, while early termination may add a fee. Obtain the complete payment schedule and sensor budget before joining.

  • The starting price does not establish every dose, full-term charge or renewal amount.
  • Continuous sensor wear requires more than the supplied periodic allowance.
  • Unused subscription time is not prorated; early termination may have a fee.
  • Assigned pharmacy, funded labs and exact injection-supply quantities need confirmation.

Weigh these trade-offs against the costs, care and terms above. For questions to ask before enrolling, see our vendor red-flags guide.

Questions about Signos

Does $199 cover any GLP-1 prescription at every dose?

It is an advertised starting price for eligible Signos+ members, not an every-dose guarantee. Ask which compounded medication, dose and quantity are proposed, the complete 12- or 24-week charge, and the continuing rate. The cheaper CGM-only plans do not establish a medication price.

Can I wear a glucose sensor continuously for the whole plan?

The Signos+ guide supplies two 15-day Stelo sensors for 12 weeks or four for 24 weeks. These support periodic use, not continuous coverage for the whole term. The guide lists extra sensors at $99 per two-pack; confirm the amount you need and their current price.

What happens to payments if I cancel?

Use Cancel Renewal in the app under Manage Subscription and confirm the cancellation. Renewal stops at the end of the current term, while remaining payments continue as scheduled. Unused time is not prorated and early termination may carry a fee. Ask support for the applicable fee and effective date before relying on an early exit.

Will I get a refund if I am ineligible or miss a check-in?

The Signos+ help page promises a full refund if a clinician finds you ineligible. It separately excludes refunds for refills missed because required check-ins were incomplete. The guide calls for monthly wellness check-ins, so confirm how to complete them and how any clinical treatment change affects your paid plan.

Who provides care, and are blood tests included?

Signos is the platform; OpenLoop Health and independent clinician networks assess and prescribe. Updated laboratory testing may be needed depending on your history, but a funded test panel and payer are not confirmed. Ask for your assigned clinician and pharmacy, laboratory charges and injection materials before fulfillment.

Which medications and states does Signos+ advertise?

The GLP-1 page names compounded semaglutide and tirzepatide and advertises service in 49 states plus DC, excluding Louisiana. Your clinician selects treatment and determines eligibility. Some locations require video visits; general age guidance is 18–74, with Nebraska requiring 19 or older. Confirm your own location and medical eligibility; broader CGM shipping coverage does not override those limits.

Similar providers

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Provider offers and terms are based on Signos's public information. Other sources, where used, are identified in this review. Prices and terms change without notice — confirm on Signos's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.